Reports - Pharmacogenomics Market
HealthcarePharmacogenomics Market
Pharmacogenomics Market Valuation and Future Projections to 2035 by Product & Service (Kits & Reagent, Service) by Technology (Sequencing, PCR, Microarray, Other technologies) by Application (Personalized Medicine, Clinical Research, Drug Discovery & Preclinical Development) by Disease Area (Cancer, Cardiovascular, Neurological Diseases, Other Disease Areas) by End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Pharmacogenomics Market - Segment Analysis
1. Overview
2. Global Pharmacogenomics Market, 2021 - 2035 (USD Million)
3. Global Pharmacogenomics Market - by Product & Service
3.1. By Kits & Reagent
3.2. By Service
4. Global Pharmacogenomics Market - by Technology
4.1. By Sequencing
4.2. By PCR
4.3. By Microarray
4.4. By Other Technologies
5. Global Pharmacogenomics Market - by Application
5.1. By Personalized Medicine
5.2. By Clinical Research
5.3. By Drug Discovery & Preclinical Development
6. Global Pharmacogenomics Market - by Disease Area
6.1. By Cancer
6.2. By Cardiovascular
6.3. By Neurological Diseases
6.4. By Other Disease Areas
7. Global Pharmacogenomics Market - by End User
7.1. By Academic & Research Institutes
7.2. By Pharmaceutical & Biotechnology Companies
7.3. By Contract Research Organizations
8. Global Pharmacogenomics Market - by region
8.1. North America
8.2. Europe
8.3. Asia Pacific
8.4. Latin America
8.5. Middle East & Africa
9. Market comparative analysis
Chapter 4 North America Pharmacogenomics Market - Segment Analysis
1. Overview
2. North America Pharmacogenomics Market, 2021 - 2035 (USD Million)
3. North America Pharmacogenomics Market - by Product & Service
3.1. By Kits & Reagent
3.2. By Service
4. North America Pharmacogenomics Market - by Technology
4.1. By Sequencing
4.2. By PCR
4.3. By Microarray
4.4. By Other Technologies
5. North America Pharmacogenomics Market - by Application
5.1. By Personalized Medicine
5.2. By Clinical Research
5.3. By Drug Discovery & Preclinical Development
6. North America Pharmacogenomics Market - by Disease Area
6.1. By Cancer
6.2. By Cardiovascular
6.3. By Neurological Diseases
6.4. By Other Disease Areas
7. North America Pharmacogenomics Market - by End User
7.1. By Academic & Research Institutes
7.2. By Pharmaceutical & Biotechnology Companies
7.3. By Contract Research Organizations
Chapter 5 Europe Pharmacogenomics Market - Segment Analysis
1. Overview
2. Europe Pharmacogenomics Market, 2021 - 2035 (USD Million)
3. Europe Pharmacogenomics Market - by Product & Service
3.1. By Kits & Reagent
3.2. By Service
4. Europe Pharmacogenomics Market - by Technology
4.1. By Sequencing
4.2. By PCR
4.3. By Microarray
4.4. By Other Technologies
5. Europe Pharmacogenomics Market - by Application
5.1. By Personalized Medicine
5.2. By Clinical Research
5.3. By Drug Discovery & Preclinical Development
6. Europe Pharmacogenomics Market - by Disease Area
6.1. By Cancer
6.2. By Cardiovascular
6.3. By Neurological Diseases
6.4. By Other Disease Areas
7. Europe Pharmacogenomics Market - by End User
7.1. By Academic & Research Institutes
7.2. By Pharmaceutical & Biotechnology Companies
7.3. By Contract Research Organizations
Chapter 6 Asia Pacific Pharmacogenomics Market - Segment Analysis
1. Overview
2. Asia Pacific Pharmacogenomics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Pharmacogenomics Market - by Product & Service
3.1. By Kits & Reagent
3.2. By Service
4. Asia Pacific Pharmacogenomics Market - by Technology
4.1. By Sequencing
4.2. By PCR
4.3. By Microarray
4.4. By Other Technologies
5. Asia Pacific Pharmacogenomics Market - by Application
5.1. By Personalized Medicine
5.2. By Clinical Research
5.3. By Drug Discovery & Preclinical Development
6. Asia Pacific Pharmacogenomics Market - by Disease Area
6.1. By Cancer
6.2. By Cardiovascular
6.3. By Neurological Diseases
6.4. By Other Disease Areas
7. Asia Pacific Pharmacogenomics Market - by End User
7.1. By Academic & Research Institutes
7.2. By Pharmaceutical & Biotechnology Companies
7.3. By Contract Research Organizations
Chapter 7 Latin America Pharmacogenomics Market - Segment Analysis
1. Overview
2. Latin America Pharmacogenomics Market, 2021 - 2035 (USD Million)
3. Latin America Pharmacogenomics Market - by Product & Service
3.1. By Kits & Reagent
3.2. By Service
4. Latin America Pharmacogenomics Market - by Technology
4.1. By Sequencing
4.2. By PCR
4.3. By Microarray
4.4. By Other Technologies
5. Latin America Pharmacogenomics Market - by Application
5.1. By Personalized Medicine
5.2. By Clinical Research
5.3. By Drug Discovery & Preclinical Development
6. Latin America Pharmacogenomics Market - by Disease Area
6.1. By Cancer
6.2. By Cardiovascular
6.3. By Neurological Diseases
6.4. By Other Disease Areas
7. Latin America Pharmacogenomics Market - by End User
7.1. By Academic & Research Institutes
7.2. By Pharmaceutical & Biotechnology Companies
7.3. By Contract Research Organizations
Chapter 8 Middle East & Africa Pharmacogenomics Market - Segment Analysis
1. Overview
2. Middle East & Africa Pharmacogenomics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Pharmacogenomics Market - by Product & Service
3.1. By Kits & Reagent
3.2. By Service
4. Middle East & Africa Pharmacogenomics Market - by Technology
4.1. By Sequencing
4.2. By PCR
4.3. By Microarray
4.4. By Other Technologies
5. Middle East & Africa Pharmacogenomics Market - by Application
5.1. By Personalized Medicine
5.2. By Clinical Research
5.3. By Drug Discovery & Preclinical Development
6. Middle East & Africa Pharmacogenomics Market - by Disease Area
6.1. By Cancer
6.2. By Cardiovascular
6.3. By Neurological Diseases
6.4. By Other Disease Areas
7. Middle East & Africa Pharmacogenomics Market - by End User
7.1. By Academic & Research Institutes
7.2. By Pharmaceutical & Biotechnology Companies
7.3. By Contract Research Organizations
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Illumina Inc. (U.S.)
2. Thermo Fisher Scientific Inc. (U.S.)
3. Danaher Corporation (U.S.)
4. Laboratory Corporation of America Holdings (U.S.)
5. Charles River Laboratories (U.S.)
6. Eurofins Scientific (Luxembourg)
7. Bio-Rad Laboratories Inc. (U.S.)
8. Agilent Technologies Inc. (U.S.)
9. Becton Dickinson and Company (U.S.)
10. QIAGEN (Germany)
11. F. Hoffmann-La Roche Ltd. (Switzerland)
12. Revvity (U.S.)
13. IQVIA Inc. (U.S.)
14. Mesa Labs Inc. (U.S.)
15. Medpace (U.S.)
16. MGI Tech Co. Ltd. (China)
17. Takara Bio Inc. (U.S.)
18. PacBio (U.S.)
19. New England Biolabs (U.S.)
20. BGI Genomics (China)
21. Novogene Co. Ltd. (China)
22. Sophia Genetics (Switzerland)
23. Fios Genomics (UK)
24. Personalis Inc. (U.S.)
25. BioAI Health Inc. (U.S.)
26. NeoGenomics Laboratories (U.S.)
27. Macrogen Inc. (South Korea)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By